dtpcrm: Dose Transition Pathways with Continual Reassessment Method
Description | Getting started | Design a CRM trial with DTP as a calibration tool | CRM Design Considerations | 1. Clinical Parameters | 2. Model Specification Parameters | 3. Practical Considerations | Simulations: assess operating characteristics of the proposed CRM design | Simulation Results | DTP for initial cohorts | Displaying DTP in a table format | Displaying DTP as a flow diagram | Trial Conduct with DTP | Model Updates with accumulated information | Update of Dose Toxicity Curves | Update DTP for Subsequent Cohorts | DTP table for Cohorts 3 to 6 | DTP flow diagram for Cohorts 3 to 5 | References